Award
Delivery Order #SPE2DP26F2987
Delivery Order for Cyclobenzaprine Hydrochloride Under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$47.01
Ceiling
$47.01
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Mar 09, 2026
Identifier
SPE2DP26F2987
NAICS
424210
This award is a delivery order contract under a larger indefinite delivery vehicle (IDV) pharmaceutical supply contract. The recipient, DMS Pharmaceutical Group Inc., a specialized pharmaceutical distributor, is tasked with providing Cyclobenzaprine Hydrochloride, a muscle relaxant medication. This procurement is significant as it supports ongoing federal health agency needs for essential medications, ensuring timely access to critical drug inventories. The scope involves the delivery of this specific pharmaceutical product to a designated location in Park Ridge, Illinois. The award process aligns with a multi-year strategic pharmaceutical supply contract, indicating coordinated procurement rather than a sole-source award. The performance period for this delivery order spans a short, defined interval within early 2026, highlighting its role as a scheduled replenishment. This delivery order complements the parent definitive contract that covers a broad range of pharmaceutical supplies, reinforcing a stable healthcare provisioning system.
Description
8511936360!CYCLOBENZAPRINE HYD